Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17722312 | VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS | Non-Final OA | The Regents of the University of California |
| 17749788 | RECOMBINASE COMPOSITIONS AND METHODS OF USE | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18163607 | Peptide Conjugated Hydrogel Substrate for the Maintenance and Expansion of Human Pluripotent Stem Cells | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18327976 | MURINE-MHC-DEFICIENT HLA-TRANSGENIC NOD-MOUSE MODELS FOR T1D THERAPY DEVELOPMENT | Non-Final OA | The Jackson Laboratory |
| 18336001 | HUMAN PRIMARY MYELOFIBROSIS CELL STRAIN AND USE THEREOF | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18276164 | Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor Cells | Non-Final OA | Baylor College of Medicine |
| 17996074 | CIRCULAR RNA COMPOSITIONS AND METHODS | Final Rejection | Orna Therapeutics, Inc. |
| 18060183 | ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS | Non-Final OA | Research Development Foundation |
| 18540096 | NON-MEIOTIC ALLELE INTROGRESSION | Final Rejection | Recombinetics, Inc. |
| 17995390 | METHOD FOR PREPARING ANIMAL TISSUE-DERIVED BIOMATERIAL, ANIMAL TISSUE-DERIVED BIOMATERIAL PREPARED THEREBY, AND 3D PRINTING METHOD USING SAME | Final Rejection | T&R BIOFAB CO., LTD. |
| 18512026 | CELL REPROGRAMMING METHOD USING IMPOSITION OF PHYSICAL STIMULATION-MEDIATED ENVIRONMENTAL TRANSITION | Non-Final OA | STEMON INC. |
| 18382121 | METHOD FOR IMPROVING THE EFFECT OF THE OOCYTE CRYOPRESERVATION BY REDUCING THE MITOCHONDRIAL TEMPERATURE | Final Rejection | The First Hospital of Hebei Medical University |
| 17922692 | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD94 AND/OR NKG2A | Final Rejection | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| 18447947 | RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE | Non-Final OA | LifeEDIT Therapeutics, Inc. |
| 17596781 | NUCLEIC ACID CONSTRUCT COMPRISING 5' UTR STEM-LOOP FOR IN VITRO AND IN VIVO GENE EXPRESSION | Non-Final OA | Glycom A/S |
| 18249367 | USING ORGANOIDS AND/OR SPHEROIDS TO CULTIVATE MEAT | Non-Final OA | Orbillion Bio, Inc. |
| 18121340 | METHOD OF REPROGRAMMING CELLS | Final Rejection | ReGen Theranostics, Inc. |
| 17786483 | METHOD OF MICROGLIA DIFFERENTIATION CAPABLE OF SECURING LARGE QUANTITY OF MICROGLIA BY USING 3D ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | Final Rejection | CORESTEM CO.,LTD. |
| 17964399 | MORTAL PLURIPOTENT STEM CELLS | Non-Final OA | ACCELERATED BIOSCIENCES CORP. |
| 17790797 | METHODS AND COMPOSITIONS FOR PRODUCTION OF XENOGENEIC ISLET CELLS AND TREATMENT OF INSULIN-RESISTANT OR -DEFICIENT CONDITIONS WITH THE SAME | Final Rejection | Hangzhou Qihan Biotechnology Co., Ltd. |
| 17747557 | MEASLES VIRUS ENCODING A TUMOR ANTIGEN | Final Rejection | RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG |
| 17731112 | METHODS FOR ELECTRO-MECHANICAL TRANSFECTION | Non-Final OA | Kytopen Corporation |
| 17768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | Non-Final OA | Orchard Therapeutics (Europe) Limited |
| 16641290 | Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease | Non-Final OA | The Nippon Dental University |
| 17073580 | STABILIZATION OF NON-DENATURED POLYPEPTIDES, NUCLEIC ACIDS, AND EXOSOMES IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Non-Final OA | Biomatrica, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy